Status:

COMPLETED

Mercury Metabolism by Bacteria in Humans

Lead Sponsor:

University of Rochester

Collaborating Sponsors:

National Institute of Environmental Health Sciences (NIEHS)

Conditions:

Mercury--Toxicology

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate how the bacteria in your gut can improve the break-down and de-toxification of non-harmful levels of a naturally occurring form of mercury (methylmercury) that...

Detailed Description

The overall objective of this study is to investigate the role of gut microbes in mediating how humans metabolize and excrete the environmental neurotoxicant methylmercury (MeHg). Exposure to MeHg thr...

Eligibility Criteria

Inclusion

  • Subjects must be 18-80 years in age.
  • Subjects must be in good general health based on self-reported health status, with the exception of self-reported conditions listed in the exclusion criteria.
  • Subject must be willing to comply with study procedures.

Exclusion

  • Known allergy to fish.
  • Pregnant or lactating women.
  • Use of hair dyes or chemical treatments within the prior month and/or intent to use such treatments during the two trial periods. (Hair treatment during the washout period up to one month prior to the second trial is acceptable).
  • Known gastrointestinal or renal disorders.
  • Subjects with diminished mental capacity.
  • Use of antibiotics within two months leading up to the study.

Key Trial Info

Start Date :

October 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 31 2023

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT04060212

Start Date

October 1 2019

End Date

August 31 2023

Last Update

October 4 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Rochester Medical Center

Rochester, New York, United States, 14642